US 8426597
Nitrate derivatives of cilostazol for the treatment of vascular and metabolic diseases
granted A61PA61P3/00A61P3/06
Quick answer
US patent 8426597 (Nitrate derivatives of cilostazol for the treatment of vascular and metabolic diseases) held by CARDIOLYNX AG expires Mon Apr 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CARDIOLYNX AG
- Grant date
- Tue Apr 23 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61P, A61P3/00, A61P3/06, A61P9/00, A61P9/10